Sol-Gel Technologies (SLGL) Enterprise Value (2016 - 2026)
Sol-Gel Technologies (SLGL) reported Enterprise Value of -$10.1 million for Q1 2026, up 39.99% year-over-year from -$7.2 million in Q1 2025, and up 8.13% quarter-over-quarter from -$11.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Enterprise Value (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Enterprise Value data on file, last reported at -$10.1 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$10.1 million, up 39.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.1 million (up 39.99% YoY), and the FY2025 annual result was -$11.0 million, up 43.42% from the prior year.
- Enterprise Value grew to -$10.1 million in Q1 2026 per SLGL's latest filing, from -$11.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$6.2 million in Q2 2022 and troughed at -$28.0 million in Q4 2023.
- A 5-year average of -$14.0 million and a median of -$13.4 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value surged 80.39% in 2022, then sank 135.28% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$21.1 million in 2022, then sank by 32.46% to -$28.0 million in 2023, then surged by 30.31% to -$19.5 million in 2024, then soared by 43.42% to -$11.0 million in 2025, then gained by 8.13% to -$10.1 million in 2026.
- Business Quant data shows SLGL's Enterprise Value at -$10.1 million in Q1 2026, -$11.0 million in Q4 2025, and -$6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - | -10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.14 Mn |
| Dec 31, 2025 | -11.03 Mn |
| Sep 30, 2025 | -6.71 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -16.89 Mn |
| Dec 31, 2024 | -19.50 Mn |
| Sep 30, 2024 | -13.42 Mn |
| Jun 30, 2024 | -17.55 Mn |
| Mar 31, 2024 | -11.21 Mn |
| Dec 31, 2023 | -27.98 Mn |
| Sep 30, 2023 | -14.14 Mn |
| Jun 30, 2023 | -14.62 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -21.13 Mn |
| Sep 30, 2022 | -8.50 Mn |
| Jun 30, 2022 | -6.21 Mn |
| Mar 31, 2022 | -21.25 Mn |
| Dec 31, 2021 | -21.79 Mn |
| Sep 30, 2021 | -43.35 Mn |
| Jun 30, 2021 | -11.65 Mn |